
Sunshail Pharma Llp
Founded in 2018 and headquartered in Maharashtra, India.
Founded in 2018 and headquartered in Maharashtra, India.
Sunshail Pharma Llp (SPL) is 6 Year, 9 Months old Limited Liability Partnership 07 August 2018. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
AAN-1148
07 Aug 2018
31 Mar 2023
Roc-Mumbai
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arendra Tiwari ![]() | Designated Partner | 07-Aug-2018 | Current |
Shailendra Tiwari ![]() | Designated Partner | 07-Aug-2018 | Current |
Enhance accessibility to Sunshail Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Sunshail Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Arendra Tiwari is a mutual person
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Sunshail Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sunshail Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunshail Pharma Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sunshail Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Mumbai.
Arendra Kumar Govindprasad Tiwari was appointed as a Designated Partner was appointed as a Designated Partner on 07 Aug 2018 & has been associated with this company since 6 years 9 months .
Shailendra Govind Prasad Tiwari was appointed as a Designated Partner was appointed as a Designated Partner on 07 Aug 2018 & has been associated with this company since 6 years 9 months .
Sunshail Pharma Llp was registered on 07 Aug 2018 with RoC-Mumbai & aged 6 years 9 months as per MCA records.
Sunshail Pharma Llp was incorporated on 07 Aug 2018.
The Obligation of Contribution of Sunshail Pharma Llp is ₹ 0.10 M.
Currently 2 partners are associated with Sunshail Pharma Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Sunshail Pharma Llp is Floor-Grd Nehru Nagar Hemant Manjarekar Marg Raoli Camp, Antop Hill Na City, Mumbai, Maharashtra, India, 400037.
The Limited Liability Partnership Identification Number (LLPIN) of Sunshail Pharma Llp is AAN-1148.
The most recent Balance Sheet for Sunshail Pharma Llp was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.